0000899243-19-003603.txt : 20190214
0000899243-19-003603.hdr.sgml : 20190214
20190214160658
ACCESSION NUMBER: 0000899243-19-003603
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190212
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Paul Francis
CENTRAL INDEX KEY: 0001714565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 19606146
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET, SUITE 320
STREET 2: C/O SYNLOGIC, INC.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-12
0
0001527599
SYNLOGIC, INC.
SYBX
0001714565
Miller Paul Francis
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2019-02-12
4
S
0
3151
9.75
D
53984
D
Common Stock
2019-02-13
4
S
0
5849
9.75
D
48135
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018.
/s/ William J. Bussiere, Jr., Attorney-in-fact
2019-02-14